Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

106 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparison of biodegradable and newer generation durable polymer drug-eluting stents with short-term dual antiplatelet therapy: a systematic review and Bayesian network meta-analysis of randomized trials comprising of 43,875 patients.
Chong B, Goh RSJ, Kong G, Sim FRE, Ng CH, Teo XYV, Quek JX, Lim O, Chin YH, Chan SP, Chan MY, Tan HC, Chew NWS, Loh PH. Chong B, et al. Among authors: loh ph. J Thromb Thrombolysis. 2022 Apr;53(3):671-682. doi: 10.1007/s11239-021-02628-8. Epub 2022 Jan 4. J Thromb Thrombolysis. 2022. PMID: 34981305
Incidence and predictors of target lesion failure in a multiethnic Asian population receiving the SYNERGY coronary stent: A prospective all-comers registry.
Ananthakrishna R, Kristanto W, Liu L, Chan SP, Loh PH, Tay EL, Chan KH, Chan MY, Lee CH, Low AF, Tan HC, Loh JP. Ananthakrishna R, et al. Among authors: loh ph, loh jp. Catheter Cardiovasc Interv. 2018 Nov 15;92(6):1097-1103. doi: 10.1002/ccd.27577. Epub 2018 Mar 7. Catheter Cardiovasc Interv. 2018. PMID: 29513378
Clinical Outcomes One Year and Beyond After Combination Sirolimus-Eluting Endothelial Progenitor Cell Capture Stenting During Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction.
Sim HW, Thong EH, Tan HC, Low AF, Lee CH, Chan MY, Tay EL, Loh PH, Chan KH, Loh JP. Sim HW, et al. Among authors: loh ph, loh jp. Cardiovasc Revasc Med. 2019 Sep;20(9):739-743. doi: 10.1016/j.carrev.2018.11.004. Epub 2018 Nov 7. Cardiovasc Revasc Med. 2019. PMID: 30442536
Impact of the COVID-19 Pandemic on Door-to-Balloon Time for Primary Percutaneous Coronary Intervention　- Results From the Singapore Western STEMI Network.
Chew NW, Sia CH, Wee HL, Benedict LJ, Rastogi S, Kojodjojo P, Chor WPD, Leong BS, Koh BC, Tam H, Quek LS, Sia WC, Saw KW, Tung BW, Ng ZZ, Ambhore A, Tay EL, Chan KH, Lee CH, Loh JP, Low AF, Chan MY, Yeo TC, Tan HC, Loh PH. Chew NW, et al. Among authors: loh ph, loh jp. Circ J. 2021 Jan 25;85(2):139-149. doi: 10.1253/circj.CJ-20-0800. Epub 2020 Nov 7. Circ J. 2021. PMID: 33162491 Free article. Clinical Trial.
Characteristics and outcomes of young patients with ST segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: retrospective analysis in a multiethnic Asian population.
Tung BW, Ng ZY, Kristanto W, Saw KW, Chan SP, Sia W, Chan KH, Chan M, Kong W, Lee R, Loh JP, Low AF, Poh KK, Tay E, Tan HC, Yeo TC, Loh PH. Tung BW, et al. Among authors: loh ph, loh jp. Open Heart. 2021 Jan;8(1):e001437. doi: 10.1136/openhrt-2020-001437. Open Heart. 2021. PMID: 33441469 Free PMC article.
Long-Term Clinical Outcomes of Biodegradable-Polymer Drug-Eluting Stents Versus Second-Generation Durable-Polymer Drug-Eluting Stents for ST-Segment Elevation Myocardial Infarction.
Sim HW, Thong EH, Djohan AH, Chen JZ, Ser JS, Loh PH, Lee CH, Chan MY, Low AF, Tay EL, Chan KH, Tan HC, Loh JP. Sim HW, et al. Among authors: loh ph, loh jp. Cardiovasc Revasc Med. 2022 Feb;35:98-103. doi: 10.1016/j.carrev.2021.04.014. Epub 2021 Apr 16. Cardiovasc Revasc Med. 2022. PMID: 33893053
106 results